Presentation THT 2022 EMPULSE: The Use of SGLT2 Inhibitors in Acute Decompensated Heart Failure Presenter: Piotr Ponikowski February 01, 2022
News Conference News THT 2022 REDUCE LAP-HF II: Atrial Shunt Device Comes Up Short in HFpEF Shelley Wood February 01, 2022
Presentation THT 2022 CON - Patients with Group 2 Pulmonary Hypertension are not candidates for interatrial shunts! Presenter: Liviu Klein February 01, 2022
Presentation THT 2022 PRO - Patients with Group 2 Pulmonary Hypertension are not candidates for interatrial shunts! Presenter: Roham Zamanian February 01, 2022
Presentation THT 2022 CON - PRO - LA decompression is unnecessary in the era of SGLT2 inhibitors and ARNI's! Presenter: Sanjiv Shah February 01, 2022
Presentation THT 2022 PRO - LA decompression is unnecessary in the era of SGLT2 inhibitors and ARNI's! Presenter: Alanna Morris February 01, 2022
Presentation THT 2022 Right heart catheterization + Exercise testing – best practices for treatment selection in patients with PH due to Left Heart Disease Presenter: Ryan Tedford February 01, 2022
Presentation THT 2022 Timing of Intervention and the fate of the RV Presenter: Barry Borlaug February 01, 2022
News Daily News In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report Michael O'Riordan January 27, 2022
News Features Realistic Expectations Emerge After Initial Excitement Over Xenotransplant Yael L. Maxwell January 21, 2022
News Daily News Journal of Cardiac Failure Launches Rapid Publication Platform to Spark Discourse Todd Neale January 21, 2022
News Opinion Fellow Talk A Trainee’s Perspective on the First Genetically Engineered Pig-to-Human Cardiac Xenotransplantation Corbin E. Goerlich, MD January 13, 2022
News Daily News Using Donor Hearts After Circulatory Death Is Feasible for Transplantation Michael O'Riordan January 12, 2022
News Daily News With First-in-Human Porcine Heart Transplant, a New Chapter Begins Yael L. Maxwell January 11, 2022